At the University of Chicago, scientists have developed an absolutely innovative, promising treatment for COVID-19 in the form of nanoparticles with the ability to trap SARS-CoV-2 viruses inside the body and use the body’s own immune system to kill them.
The “nanotraps” lure the virus by imitating the target cells infected by the virus. When the virus gets trapped by the nanotraps, it is then sequestered from other cells and targeted for destruction by the immune system.
Theoretically, these nanotraps could be used on different variants of the virus, resulting in a promising new way to suppress the virus in the future. The therapy is still in the early stages of testing, but the researchers believe that it could be administered through a nasal spray as a treatment for COVID-19.
The findings of the study were published in the journal Matter on April 19th, 2021.
Since the pandemic began, our research team has been developing this new way to treat COVID-19. We have done rigorous testing to prove that these nanotraps work, and we are excited about their potential.
Jun Huang, Assistant Professor, Pritzker School of Molecular Engineering
The study was led by Huang’s lab.
Designing the Perfect Trap
Led by postdoctoral scholar Min Chen and graduate student Jill Rosenberg, the researchers designed the nanotrap by analyzing the mechanism used by SARS-CoV-2 to bind to cells—a spike-like protein on its surface that attaches itself to the ACE2 receptor protein found on a human cell.
The nanoparticles are made of FDA-approved polymers and phospholipids with a diameter of about 500 nm—quite smaller than a cell. This implies that the nanotraps can reach more areas within the body and capture the virus more effectively.
To ensure the tiny particles appeared the same way they expected, the researchers collaborated with the lab of Associate Professor Bozhi Tian to employ electron microscopes to achieve a better look.
From our imaging, we saw a solid core and a lipid bilayer shell. That’s the essential part because it mimics the cell.
Bozhi Tian, Associate Professor, Department of Chemistry, University of Chicago
The safety of the system was tested by the researchers in a mouse model, and no toxicity was found. Then, the nanotraps were tested against a pseudovirus, which is a less potent model of a virus that does not replicate, in human lung cells in tissue culture plates. It was found that they totally blocked the entry of the pseudovirus into the cells.
As soon as the pseudovirus attached itself to the nanoparticle—which took about 10 minutes after injection during the tests—the nanoparticles used a molecule that summons the macrophages in the body to engulf and disintegrate the nanotrap.
In general, macrophages eat nanoparticles inside the body. However, the nanotrap molecule accelerates the process. It was found that the nanoparticles were cleared and disintegrated within 48 hours.
The nanoparticles were also with a pseudovirus in an ex vivo lung perfusion system—a pair of donated lungs maintained alive with a ventilator—and it was discovered that they totally blocked infection in the lungs.
Moreover, they collaborated with scientists at Argonne National Laboratory to test the nanotraps using a live virus (instead of a pseudovirus) in an in vitro system. Their system was found to inhibit the virus 10 times better than neutralizing antibodies or soluble ACE2 alone.
Image Credit: Chen and Rosenberg et al.
Researchers from Hong Kong Baptist University (HKBU), in collaboration with Cornell University, have developed a novel targeted therapy for triple-negative breast cancer (TNBC) that uses a specially-designed nano-carrier to deliver the Chinese medicine compound [...]
By early 2020, concern was mounting about a new, deadly coronavirus first detected in Wuhan, China. The World Health Organization had declared the coronavirus outbreak a global health emergency just days before. There had been [...]
As a COVID-19 and medical device researcher, I understand the importance of face masks to prevent the spread of the coronavirus. So I am intrigued that some mask manufacturers have begun adding graphene coatings [...]
Swansea University scientists have uncovered potentially dangerous chemical pollutants that are released from disposable face masks when submerged in water. The research reveals high levels of pollutants, including lead, antimony, and copper, within the [...]
Bowel cancer survival rates could be improved if chemotherapy drugs were delivered via tiny nanoparticles to the diseased organs rather than oral treatment. That's the finding from Indian and Australian scientists who have undertaken [...]
Pfizer CEO Albert Bourla says his company’s experimental COVID-19 treatment, a pill that can be taken at the first sign of the illness, could be available before the end of the year. Speaking on CNBC, Bourla said clinical [...]
At the University of Chicago, scientists have developed an absolutely innovative, promising treatment for COVID-19 in the form of nanoparticles with the ability to trap SARS-CoV-2 viruses inside the body and use the body’s [...]
Australian researchers have identified neutralizing nanobodies that block the SARS-CoV-2 virus from entering cells in preclinical models. The discovery paves the way for further investigations into nanobody-based treatments for COVID-19. Published in PNAS, the research [...]
Someday, scientists believe, tiny DNA-based robots and other nanodevices will deliver medicine inside our bodies, detect the presence of deadly pathogens, and help manufacture increasingly smaller electronics. Researchers took a big step toward that [...]
Experts have discovered what they believe is the world’s most mutated COVID strain – and there’s one detail in particular that has scientists worried. Scientists have detected what is believed to be the world’s [...]
SARS-CoV-2, the virus that causes COVID-19, likely does not directly infect the brain but can still inflict significant neurological damage, according to a new study from neuropathologists, neurologists, and neuroradiologists at Columbia University Vagelos [...]
ANSTO has contributed to a comprehensive investigation of a promising type of nanoparticle that could potentially be used for intractable brain cancers in a combined therapy. The study, which was led by Dr. Moeava [...]
The immune response needed to protect people against reinfection with the coronavirus will be explored in a new human challenge trial, researchers have revealed. Human challenge trials involve deliberately exposing healthy people to a [...]
Researchers from Duke University are developing a flu shot with the new technology that was used for two coronavirus vaccines. Both the Pfizer-BioNTech and the Moderna shots use part of the virus's genetic code [...]
Researchers from the University of Liverpool have shown the potential of repurposing an existing and cheap drug into a long-acting injectable therapy that could be used to treat Covid-19. In a paper published in the journal Nanoscale, [...]